Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Scientific Reports
|
July 20, 2016
MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
Morten Lapin, Kjersti Tjensvoll, Satu Oltedal, et al.
BMC Cancer
|
June 2, 2017
Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells
Morten Lapin, Kjersti Tjensvoll, Satu Oltedal, et al.
Plos One
|
September 14, 2023
Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer
Morten Lapin, Kjersti Tjensvoll, Karoline Nedrebø, et al.
Scientific Reports
|
April 7, 2022
Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
Kjersti Tjensvoll, Morten Lapin, Bjørnar Gilje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Morten Lapin, Karin H Edland, Kjersti Tjensvoll, et al.
Molecular Oncology
|
June 21, 2023
Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
Karin Hestnes Edland, Kjersti Tjensvoll, Satu Oltedal, et al.
Frontiers in Immunology
|
December 23, 2024
Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes
Irene T Ovestad, Ingvild Dalen, Kristiane Soreng, et al.
Molecular Oncology
|
January 5, 2016
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
Kjersti Tjensvoll, Morten Lapin, Tove Buhl, et al.
Molecular Oncology
|
August 26, 2025
Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Scientific Reports
|
July 20, 2016
MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
Morten Lapin, Kjersti Tjensvoll, Satu Oltedal, et al.
BMC Cancer
|
June 2, 2017
Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells
Morten Lapin, Kjersti Tjensvoll, Satu Oltedal, et al.
Plos One
|
September 14, 2023
Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer
Morten Lapin, Kjersti Tjensvoll, Karoline Nedrebø, et al.
Scientific Reports
|
April 7, 2022
Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
Kjersti Tjensvoll, Morten Lapin, Bjørnar Gilje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Morten Lapin, Karin H Edland, Kjersti Tjensvoll, et al.
Molecular Oncology
|
June 21, 2023
Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
Karin Hestnes Edland, Kjersti Tjensvoll, Satu Oltedal, et al.
Frontiers in Immunology
|
December 23, 2024
Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes
Irene T Ovestad, Ingvild Dalen, Kristiane Soreng, et al.
Molecular Oncology
|
January 5, 2016
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
Kjersti Tjensvoll, Morten Lapin, Tove Buhl, et al.
Molecular Oncology
|
August 26, 2025
Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
Page
of 2